George Baillie on peptide array, a technique that transformed research on phosphodiesterases

George Baillie speaks to Francesca Lake (Managing Editor, Future Science OA). George Baillie is a Professor and PI within the Institute of Cardiovascular and Medical Sciences at the University of Glasgow (Glasgow, UK). His research over the last 15 years has examined many aspects of the cAMP signaling pathway in disease and he has published over 140 papers on the subject. His major discovery was that phosphodiesterases are ‘compartmentalized’, and it is their location within cells that direct their function. The Baillie/Houslay laboratory was the first to discover a specific function for a single isoform of PDE4 (namely PDE4D5 with β-arrestin desensitizes the β2-adrenergic receptor). His laboratory has since gone on to ascribe functions to several other PDE4 isoforms. He is a founder and director of Sannox Therapeutics, a spin-out venture within University of Glasgow. He is also a member of the Editorial Board of Future Science OA and Co-Editor of Cellular Signalling

Editorial

No abstract available

Smooth Random Surfaces from Tight Immersions?

We investigate actions for dynamically triangulated random surfaces that consist of a gaussian or area term plus the {\it modulus} of the gaussian curvature and compare their behavior with both gaussian plus extrinsic curvature and ``Steiner'' actions.Comment: 7 page

Editorial: frontiers in the pharmacological manipulation of intracellular cAMP levels

No abstract available

Validation of a bovine rectal palpation simulator for training veterinary students

No abstract available

Non-genetic therapeutic approaches to Canavan disease

Canavan disease (CD) is a rare leukodystrophy characterized by diffuse spongiform white matter degeneration, dysmyelination and intramyelinic oedema with consequent impairment of psychomotor development and early death. The molecular cause of CD has been identified as being mutations of the gene encoding the enzyme aspartoacylase (ASPA) leading to its functional deficiency. The physiological role of ASPA is to hydrolyse N-acetyl-l-aspartic acid (NAA), producing l-aspartic acid and acetate; as a result, its deficiency leads to abnormally high central nervous system NAA levels. The aim of this article is to review what is currently known regarding the aetiopathogenesis and treatment of CD, with emphasis on the non-genetic therapeutic strategies, both at an experimental and a clinical level, by highlighting: (a) major related hypotheses, (b) the results of the available experimental simulatory approaches, as well as (c) the relevance of the so far examined markers of CD neuropathology. The potential and the limitations of the current non-genetic neuroprotective approaches to the treatment of CD are particularly discussed in the current article, in a context that could be used to direct future experimental and (eventually) clinical work in the field

The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer's disease

Alzheimer's disease (AD) is the most common form of dementia in the elderly and its prevalence is set to increase rapidly in coming decades. However, there are as yet no available drugs that can halt or even stabilize disease progression. One of the main pathological features of AD is the presence in the brain of senile plaques mainly composed of aggregated β amyloid (Aβ), a derivative of the longer amyloid precursor protein (APP). The amyloid hypothesis proposes that the accumulation of Aβ within neural tissue is the initial event that triggers the disease. Here we review research efforts that have attempted to inhibit the generation of the Aβ peptide through modulation of the activity of the proteolytic secretases that act on APP and discuss whether this is a viable therapeutic strategy for treating AD.<p></p> Alzheimer's disease (AD) is the most common form of dementia in the elderly but as yet there are no drugs that can halt the progression of this disease. In a theory called the ‘amyloid hypothesis’, researchers have proposed that the accumulation of a small protein fragment called beta amyloid or Aβ within brain tissue is the event which triggers Alzheimer's disease. Aβ is a derivative of the longer amyloid precursor protein (APP). Here we review research efforts that have attempted to inhibit the generation of Aβ through modulation of proteins called secretases which cut APP into Aβ. Author edits made on: 20 May 2015

Shear wave generation using a spiral electromagnetic acoustic transducer

A spiral electromagnetic acoustic transducer (EMAT) is efficient in eddy current generation and has been used for surface defect inspection using Rayleigh waves or thickness gauging based on plane waves in echo mode. Measured and calculated particle velocities and directivities are presented. It is found that the shear wave is not predominantly a plane wave. It has zero amplitude on the axis of the generation EMAT and has maximum amplitude at the critical angle. The shear wave could be used in the steel industry for both internal and surface defect inspections together with Rayleigh wave

Ising Model Coupled to Three-Dimensional Quantum Gravity

We have performed Monte Carlo simulations of the Ising model coupled to three-dimensional quantum gravity based on a summation over dynamical triangulations. These were done both in the microcanonical ensemble, with the number of points in the triangulation and the number of Ising spins fixed, and in the grand canoncal ensemble. We have investigated the two possible cases of the spins living on the vertices of the triangulation (``diect'' case) and the spins living in the middle of the tetrahedra (``dual'' case). We observed phase transitions which are probably second order, and found that the dual implementation more effectively couples the spins to the quantum gravity.Comment: 11 page